About
Daclatasvir is a direct-acting antiviral agent specifically designed for the treatment of chronic Hepatitis C virus (HCV) infection. It belongs to a class of medications known as NS5A inhibitors, which target a crucial protein involved in HCV replication. By inhibiting the NS5A protein, daclatasvir effectively blocks the virus's ability to multiply and spread within the body. It is typically used in combination with other antiviral drugs, such as sofosbuvir, to achieve high sustained virologic response rates across various HCV genotypes, including genotypes 1, 3, and 4. This combination therapy offers a potent, all-oral regimen that has revolutionized HCV treatment, providing a cure for many patients.
Uses
- Treatment of chronic Hepatitis C virus (HCV) infection.
- Effective against HCV genotypes 1, 3, and 4.
- Used in combination with other antiviral agents.
- Part of an all-oral regimen for HCV.
Directions For Use
Take one tablet orally once daily, with or without food, exactly as prescribed by your physician.
Benefits
- High sustained virologic response rates for HCV.
- Effective across multiple HCV genotypes.
- Part of an all-oral, interferon-free treatment regimen.
- Generally well-tolerated with a favorable safety profile.
- Significantly reduces viral load and risk of liver complications.
- Offers a potential cure for chronic Hepatitis C.
Side Effects
- Headache
- Fatigue
- Nausea
- Diarrhea
- Insomnia
- Anemia
- Rash
- Itching
- Muscle pain
- Joint pain
- Irritability
- Decreased appetite
Safety Measures
- Alcohol - Alcohol consumption should be avoided or significantly limited, as it can exacerbate liver disease and potentially interfere with the medication's effectiveness.
- Pregnancy - Not recommended during pregnancy unless the potential benefits clearly outweigh the risks; consult your doctor for advice.
- Breastfeeding - It is unknown if daclatasvir is excreted in breast milk; caution is advised, and a doctor should be consulted.
- Liver - Used to treat liver disease (HCV); liver function should be monitored regularly, and dose adjustments may be necessary in severe hepatic impairment.
- Kidney - Generally safe in patients with renal impairment; no dose adjustment is typically required for mild to moderate kidney disease.
- Lung - No specific contraindications or significant adverse effects on lung function have been reported with this medication.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!